The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerosa, F.
Right arrow Articles by Trinchieri, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerosa, F.
Right arrow Articles by Trinchieri, G.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2005, 174: 727-734.
Copyright © 2005 by The American Association of Immunologists

The Reciprocal Interaction of NK Cells with Plasmacytoid or Myeloid Dendritic Cells Profoundly Affects Innate Resistance Functions1

Franca Gerosa2,*, Andrea Gobbi3,*, Penelope Zorzi3,*, Stephanie Burg{dagger}, Francine Briere{dagger}, Giuseppe Carra* and Giorgio Trinchieri{dagger}

* Department of Pathology, Section of Immunology, University of Verona, Verona, Italy; and {dagger} Schering-Plough Research Institute, Laboratory for Immunological Research, Dardilly, France

A reciprocal activating interaction between NK cells and dendritic cells (DC) has been suggested to play a role in the functional regulation of these cells in immunity, but it has been studied only using in vitro generated bone marrow- or monocyte-derived DC. We report that human peripheral blood plasmacytoid DC (pDC) and myeloid DC are necessary to induce NK cell function depending on the type of microbial stimulus. pDC and myeloid DC are required for strongly increased NK cytolytic activity and CD69 expression, in response to inactivated influenza virus or CpG-containing oligonucleotides and poly(I:C), respectively. Secreted type I IFN is required and sufficient for the augmentation of NK cell cytolytic activity in the coculture with pDC or myeloid DC, whereas CD69 expression is dependent on both type I IFN and TNF. In addition, in response to poly(I:C), myeloid DC induce NK cells to produce IFN-{gamma} through a mechanism dependent on both IL-12 secretion and cell contact between NK cells and myeloid DC, but independent of type I IFN. IL-2-activated NK cells have little to no cytolytic activity for immature myeloid DC and pDC, but are able to induce maturation of these cells. Moreover, IL-2-activated NK cells induce, in the presence of a suboptimal concentration of CpG-containing oligonucleotides, a strong IFN-{alpha} and TNF production. These data suggest that the reciprocal functional interaction between NK cells and either pDC or myeloid DC may play an important physiological role in the regulation of both innate resistance and adaptive immunity to infections.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. B. Rosen, W. Cao, D. T. Avery, S. G. Tangye, Y.-J. Liu, J. P. Houchins, and L. L. Lanier
Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
J. Immunol., May 15, 2008; 180(10): 6508 - 6517.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Guia, C. Cognet, L. de Beaucoudrey, M. S. Tessmer, E. Jouanguy, C. Berger, O. Filipe-Santos, J. Feinberg, Y. Camcioglu, J. Levy, et al.
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
Blood, May 15, 2008; 111(10): 5008 - 5016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Errington, L. Steele, R. Prestwich, K. J. Harrington, H. S. Pandha, L. Vidal, J. de Bono, P. Selby, M. Coffey, R. Vile, et al.
Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
J. Immunol., May 1, 2008; 180(9): 6018 - 6026.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Iparraguirre, J. W. Tobias, S. E. Hensley, K. S. Masek, L. L. Cavanagh, M. Rendl, C. A. Hunter, H. C. Ertl, Ulrich. H. von Andrian, and W. Weninger
Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide
J. Leukoc. Biol., March 1, 2008; 83(3): 610 - 620.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. K. Reeves and P. N. Fultz
Characterization of Plasmacytoid Dendritic Cells in Bone Marrow of Pig-Tailed Macaques
Clin. Vaccine Immunol., January 1, 2008; 15(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Z. Dudek, C. Yunis, L. I. Harrison, S. Kumar, R. Hawkinson, S. Cooley, J. P. Vasilakos, K. S. Gorski, and J. S. Miller
First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7119 - 7125.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. L. Curtis, C. M. Freeman, and J. C. Hogg
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Proceedings of the ATS, October 1, 2007; 4(7): 512 - 521.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Ebihara, H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
Int. Immunol., October 1, 2007; 19(10): 1145 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. A. Kittan, A. Bergua, S. Haupt, N. Donhauser, P. Schuster, K. Korn, T. Harrer, and B. Schmidt
Impaired Plasmacytoid Dendritic Cell Innate Immune Responses in Patients with Herpes Virus-Associated Acute Retinal Necrosis
J. Immunol., September 15, 2007; 179(6): 4219 - 4230.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chehimi, L. Azzoni, M. Farabaugh, S. A. Creer, C. Tomescu, A. Hancock, A. Mackiewicz, L. D'Alessandro, S. Ghanekar, A. S. Foulkes, et al.
Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment
J. Immunol., August 15, 2007; 179(4): 2642 - 2650.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. B. Thoren, A. Betten, A. I. Romero, and K. Hellstrand
Cutting Edge: Antioxidative Properties of Myeloid Dendritic Cells: Protection of T Cells and NK Cells from Oxygen Radical-Induced Inactivation and Apoptosis
J. Immunol., July 1, 2007; 179(1): 21 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Guan, M. Moretto, D. J. Bzik, J. Gigley, and I. A. Khan
NK Cells Enhance Dendritic Cell Response against Parasite Antigens via NKG2D Pathway
J. Immunol., July 1, 2007; 179(1): 590 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Alter, T. J. Suscovich, N. Teigen, A. Meier, H. Streeck, C. Brander, and M. Altfeld
Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells
J. Immunol., June 15, 2007; 178(12): 7658 - 7666.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Barber, T. Zhang, B. A. Gagne, and C. L. Sentman
NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model
J. Immunol., May 15, 2007; 178(10): 6140 - 6147.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Parolini, A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al.
The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues
Blood, May 1, 2007; 109(9): 3625 - 3632.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al.
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
J. Exp. Med., April 16, 2007; 204(4): 893 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Berghofer, G. Haley, T. Frommer, G. Bein, and H. Hackstein
Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-{alpha} Production
J. Immunol., April 1, 2007; 178(7): 4072 - 4079.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Draghi, A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham
NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection
J. Immunol., March 1, 2007; 178(5): 2688 - 2698.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Fujii, J. D. Trudeau, D. T. Teachey, J. D. Fish, S. A. Grupp, K. R. Schultz, and G. S. D. Reid
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Blood, March 1, 2007; 109(5): 2008 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Martinelli, C. Cicala, D. Van Ryk, D. J. Goode, K. Macleod, J. Arthos, and A. S. Fauci
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells
PNAS, February 27, 2007; 104(9): 3396 - 3401.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. H. Lim, S. Kireta, G. R. Russ, and P. T. H. Coates
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
Blood, February 1, 2007; 109(3): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Chiesa, S. Carlomagno, G. Frumento, M. Balsamo, C. Cantoni, R. Conte, L. Moretta, A. Moretta, and M. Vitale
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function
Blood, December 15, 2006; 108(13): 4118 - 4125.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X.-S. He, T. H. Holmes, C. Zhang, K. Mahmood, G. W. Kemble, D. B. Lewis, C. L. Dekker, H. B. Greenberg, and A. M. Arvin
Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines
J. Virol., December 1, 2006; 80(23): 11756 - 11766.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Chiesa, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses
Blood, December 1, 2006; 108(12): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Hosmalin and P. Lebon
Type I interferon production in HIV-infected patients
J. Leukoc. Biol., November 1, 2006; 80(5): 984 - 993.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. S. Kornbluth and G. W. Stone
Immunostimulatory combinations: designing the next generation of vaccine adjuvants
J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Mavilio, G. Lombardo, A. Kinter, M. Fogli, A. La Sala, S. Ortolano, A. Farschi, D. Follmann, R. Gregg, C. Kovacs, et al.
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection
J. Exp. Med., October 2, 2006; 203(10): 2339 - 2350.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gursel, I. Gursel, H. S. Mostowski, and D. M. Klinman
CXCL16 Influences the Nature and Specificity of CpG-Induced Immune Activation
J. Immunol., August 1, 2006; 177(3): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Montoya, H.-B. Jie, L. Al-Harthi, C. Mulder, P. J. Patino, M. T. Rugeles, A. M. Krieg, A. L. Landay, and S. B. Wilson
Activation of Plasmacytoid Dendritic Cells with TLR9 Agonists Initiates Invariant NKT Cell-Mediated Cross-Talk with Myeloid Dendritic Cells
J. Immunol., July 15, 2006; 177(2): 1028 - 1039.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Q. Wei, J. W. Stallworth, P. J. Vance, J. A. Hoxie, and P. N. Fultz
Simian Immunodeficiency Virus (SIV)/Immunoglobulin G Immune Complexes in SIV-Infected Macaques Block Detection of CD16 but Not Cytolytic Activity of Natural Killer Cells.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 768 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Taylor, M. Mohrs, and E. J. Pearce
Regulatory T Cell Responses Develop in Parallel to Th Responses and Control the Magnitude and Phenotype of the Th Effector Populatio
J. Immunol., May 15, 2006; 176(10): 5839 - 5847.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hanabuchi, N. Watanabe, Y.-H. Wang, Y.-H. Wang, T. Ito, J. Shaw, W. Cao, F. X.-F. Qin, and Y.-J. Liu
Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL)
Blood, May 1, 2006; 107(9): 3617 - 3623.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier
Natural-killer cells and dendritic cells: "l'union fait la force"
Blood, October 1, 2005; 106(7): 2252 - 2258.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
O. Atochina and D. Harn
LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction
Clin. Vaccine Immunol., September 1, 2005; 12(9): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Rossi and J. W. Young
Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity
J. Immunol., August 1, 2005; 175(3): 1373 - 1381.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Munz, R. M. Steinman, and S.-i. Fujii
Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity
J. Exp. Med., July 18, 2005; 202(2): 203 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Zanoni, M. Foti, P. Ricciardi-Castagnoli, and F. Granucci
TLR-Dependent Activation Stimuli Associated with Th1 Responses Confer NK Cell Stimulatory Capacity to Mouse Dendritic Cells
J. Immunol., July 1, 2005; 175(1): 286 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.